Market Cap

£41.98m

Change Today

Price Down-6.25p

Share Price

66.75p

TechMARK movers: Ardana falls on trial result

Date: Tuesday 13 May 2008

LONDON (ShareCast) - Drug developer Ardana fell back on a disappointing trial result for its new testosterone cream, which is now unlikely to meet the expected target for patients to get approval from the US Food and Drug Administration.

"It would be prudent to assume that a further study may be required for regulatory approval of Testosterone Cream," Ardana said.

The company added that it continues to hold discussions with potential bidders and also over licensing opportunities.

Inkjet printing specialist Xaar said gross margins across the product range are stable, operating costs continue to be controlled successfully and trading for the company as a whole for 2008 is in line with expectations.

FTSE TechMARK - Fallers
Ardana (ARA) 13.00p -17.46%
NXT (NTX) 20.75p -7.78%
Skyepharma (SKP) 9.33p -6.70%
Phytopharm (PYM) 21.00p -5.62%
Optos (OPTS) 176.00p -4.61%
Detica Group (DCA) 297.00p -3.88%
Wolfson Microelectronics (WLF) 132.50p -3.81%
Parity Group (PTY) 31.00p -3.12%
Oxford Biomedica (OXB) 23.25p -3.12%
Antisoma (ASM) 27.00p -2.70%

FTSE TechMARK - Risers

Vectura Group (VEC) 53.50p +5.94%
KCOM Group (KCOM) 55.75p +5.69%
Pace Micro (PIC) 86.00p +3.61%
Vtech (VTH) 307.50p +3.36%
Biocompatibles International (BII) 151.75p +3.06%
Renovo Group (RNVO) 34.00p +3.03%
Intec Telecom (ITL) 54.25p +2.84%
Imagination Technologies (IMG) 73.75p +2.43%
Xaar (XAR) 185.50p +1.92%
GB Group (GBG) 30.75p +1.65%

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Xaar Market Data

Currency UK Pounds
Share Price 66.75p Price Down
Change Today -6.25p
52 Week High 220.00
52 Week Low 66.75
Volume 18,796
Shares Issued 62.90m
Market Cap £41.98m
Beta 0.25
RiskGrade 376

Performance Indicators

Compare performance with the sector and the market.
Find out more
Key: vs Market vs Sector
Value
75.01% below the market average75.01% below the market average75.01% below the market average75.01% below the market average75.01% below the market average
85.92% below the sector average85.92% below the sector average85.92% below the sector average85.92% below the sector average85.92% below the sector average
Price Trend
64.43% below the market average64.43% below the market average64.43% below the market average64.43% below the market average64.43% below the market average
46.67% below the sector average46.67% below the sector average46.67% below the sector average46.67% below the sector average46.67% below the sector average
Income
57.31% below the market average57.31% below the market average57.31% below the market average57.31% below the market average57.31% below the market average
75% below the sector average75% below the sector average75% below the sector average75% below the sector average75% below the sector average
Growth
71.29% below the market average71.29% below the market average71.29% below the market average71.29% below the market average71.29% below the market average
81.54% below the sector average81.54% below the sector average81.54% below the sector average81.54% below the sector average81.54% below the sector average
Price Chg 6m
69.45% below the market average69.45% below the market average69.45% below the market average69.45% below the market average69.45% below the market average
62.67% below the sector average62.67% below the sector average62.67% below the sector average62.67% below the sector average62.67% below the sector average
P/E
12.02% above the market average12.02% above the market average12.02% above the market average12.02% above the market average12.02% above the market average
23.53% below the sector average23.53% below the sector average23.53% below the sector average23.53% below the sector average23.53% below the sector average
PEG
49.27% below the market average49.27% below the market average49.27% below the market average49.27% below the market average49.27% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Dividend Yield
21.98% below the market average21.98% below the market average21.98% below the market average21.98% below the market average21.98% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average
EPS Growth
24.28% below the market average24.28% below the market average24.28% below the market average24.28% below the market average24.28% below the market average
40% below the sector average40% below the sector average40% below the sector average40% below the sector average40% below the sector average
Operating Margin
31.90% above the market average31.90% above the market average31.90% above the market average31.90% above the market average31.90% above the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 2
Sell 0
Strong Sell 0
Total 3
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Xaar Dividends

  Latest Previous
  Interim Final
Ex-Div 27-Aug-08 14-May-08
Paid 17-Sep-08 13-Jun-08
Amount 1.00p 2.50p

Trades for 10-Oct-2008

Time Volume / Share Price
16:35 180 @ 66.75p
15:57 100 @ 69.50p
14:53 2,045 @ 66.75p
14:53 1,455 @ 67.00p
14:53 330 @ 67.00p

Xaar Key Personnel

CEO Ian Dinwoodie

Digital Look have been voted
"Best Research and Information Provider"

4th Floor, Bankside House, 107 Leadenhall Street, London EC3A 4AF.
Registered in England and Wales (registered no. 3678570).